[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369790-105":59,"doc-detail-369790-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","silencing-of-pigu-inhibits-the-progression-of-esophageal-squamous-cell-carcinoma-through-the-pi3kakt-signaling-pathway","Silencing of PIGU inhibits the progression of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway","","PIGU, a crucial subunit of the GPI-T complex, is evaluated for its oncogenic role in esophageal squamous cell carcinoma (ESCC), where its mechanism remains unclear. Expression analyses across pan-cancer datasets and TCGA-ESCA clinical relevance link high PIGU levels to tumor growth, lymphatic metastasis, and poor prognosis. Functional assays and protein analyses show PIGU knockdown suppresses migration, invasion, and proliferation, induces apoptosis, and alters EMT markers while reducing PI3K/Akt phosphorylation in vitro and in vivo, supporting PIGU as a therapeutic target and biomarker.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/silencing-of-pigu-inhibits-the-progression-of-esophageal-squamous-cell-carcinoma-through-the-pi3kakt-signaling-pathway/369790/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/silencing-of-pigu-inhibits-the-progression-of-esophageal-squamous-cell-carcinoma-through-the-pi3kakt-signaling-pathway/369790.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is PIGU and why was it studied in ESCC?","Question",{"text":112,"@type":113},"PIGU is a key subunit of the GPI-T complex. Its oncogenic role is established in some cancers, but its function in ESCC was poorly understood, motivating the study.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did silencing PIGU affect ESCC cell behavior?",{"text":117,"@type":113},"PIGU knockdown arrested the cell cycle, induced apoptosis, and significantly reduced migration, invasion, and proliferation in ESCC cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What signaling pathway changes were observed after PIGU knockdown?",{"text":121,"@type":113},"PIGU knockdown decreased phosphorylated Akt and PI3K levels, indicating suppression of PI3K/AKT signaling, alongside EMT marker changes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369790,1790216395,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSilencing of PIGU inhibits the progression of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway  \nJi Zuo1,3, Haiyang Guo1,3, Guangbing Hu1,3, Yuman HE1, Yong Tang1, Jie Li1, Yutong Cui1, Shiqi Liang1, Xinrui Chen1, Zichen Luo1, Xiaobo Wang1 & Xianfei Wang1,2􀀍  \nPhosphatidylinositol glycan anchor biosynthesis class U (PIGU), a crucial subunit of the glycosylphosphatidylinositol transamidase (GPI-T) complex, is an oncogene in hepatocellular carcinoma. However, its role in esophageal squamous cell carcinoma (ESCC) remains poorly understood. This study aims to clarify PIGU’s role and mechanisms in ESCC by analyzing its expression across pan-cancer datasets, clinical relevance in TCGA-ESCA samples, and effects on cell behavior (migration, invasion, proliferation) and signaling pathways, validated via immunohistochemistry. To examine cell behavior, we used Transwell, colony-formation, CCK-8, and wound-healing assays to assess migration, invasion, proliferation, and wound healing.The epithelial-mesenchymal transition marker levels were measured using Western blot analysis, and the cell cycle and apoptosis were assessed using flow cytometry in conjunction with western blotting. Furthermore, we used western blotting to examine proteins implicated in the PI3K/AKT signaling pathway.To further confirm PIGU’s role in ESCC progression, a subcutaneous xenograft mouse model was employed. Our findings suggest that PIGU is highly expressed in ESCC and is strongly associated with tumor growth, lymphatic metastasis and poor prognosis, and is an independent prognostic factor for ESCC patients.PIGU knockdown not only arrested the cell cycle and induced apoptosis, but also significantly reduced migration, invasion, and proliferation in ESCC cells. Additionally, vimentin and N-cadherin were downregulated when PIGU expression was silenced, although E-cadherin expression was simultaneously increased.Moreover, PIGU knockdown decreased the amount of phosphorylatedAkt and PI3K. In vivo, PIGU knockdown inhibited ESCC cell proliferation and promoted apoptosis. These findings imply that targeting PIGU may represent a promising therapeutic approach, and that PIGU could potentially serve as both a diagnostic and prognostic biomarker for esophageal squamous cell carcinoma (ESCC) .  \nKeywords PIGU, Esophageal squamous cell carcinoma, PI3K/AKT, Cell cycle, Apoptosis  \nEsophageal cancer is the 11th most commonly diagnosed cancer and the seventh leading cause of cancer death worldwide, with an estimated 511,000 new cases and 445,000 deaths in 20221. Disturbingly, China bears the greatest burden of this disease, accounting for approximately 50% of all global esophageal cancer cases and deaths each year2. Esophageal squamous cell carcinoma (ESCC) is an extremely aggressive and deadly malignancy, predominantly found in Eastern Asia, primarily in China3. It poses a significant health burden in the region, warranting immediate attention. The prognosis for advanced ESCC is exceedingly grim, with a 5-year survival rate of less than 20%4. ESCC is an especially aggressive malignancy, often diagnosed at an advanced stage, with poor prognosis, resistance to treatment, and a high recurrence rate 5–7. Current therapeutic approaches, including surgery, chemotherapy, and radiation therapy, have limited efficacy, and the development of resistance to these treatments is a common occurrence8,9. Therefore, identifying new therapeutic targets is critical for improving diagnosis, treatment, and outcomes for ESCC patients.  \nPhosphatidylinositol glycan anchor biosynthesis class U (PIGU), a key subunit of the glycosylphosphatidylinositol transamidase (GPI-T) complex10, is also known as CDC91L1 or GAB1 . The GPI-T  \n1Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.  \n2Digestive Endoscopy Center, Affiliated Hospital of North ","cbCaiokhwOrkjayR","https://ap.wps.com/l/cbCaiokhwOrkjayR","pdf",8057729,17,"English","# Introduction\n## Clinical burden of ESCC\n## PIGU and GPI-T complex background\n## Rationale for targeting PI3K/AKT signaling\n# Methods and Experimental Approach\n## Expression analysis and clinical association\n## In vitro functional assays\n## Cell cycle, apoptosis, EMT, and pathway protein analyses\n## In vivo xenograft validation\n# Results and Findings\n## PIGU expression and prognostic value\n## Effects of PIGU knockdown on tumor cell behavior\n## PI3K/Akt signaling and apoptosis changes","[{\"question\":\"What is PIGU and why was it studied in ESCC?\",\"answer\":\"PIGU is a key subunit of the GPI-T complex. Its oncogenic role is established in some cancers, but its function in ESCC was poorly understood, motivating the study.\"},{\"question\":\"How did silencing PIGU affect ESCC cell behavior?\",\"answer\":\"PIGU knockdown arrested the cell cycle, induced apoptosis, and significantly reduced migration, invasion, and proliferation in ESCC cells.\"},{\"question\":\"What signaling pathway changes were observed after PIGU knockdown?\",\"answer\":\"PIGU knockdown decreased phosphorylated Akt and PI3K levels, indicating suppression of PI3K/AKT signaling, alongside EMT marker changes.\"}]","Silencing of PIGU inhibits the progression of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway | PDF",1790184571,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7edaf85f2d9a74c9e57602652ea35c9d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbcd621870bebd2bdacf0aeb54c86bd4.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba15ac1ddab3d4cf4c3d764ba3ec248d.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7077a268cf881c74c7be4c7e66cc74cc.webp",980,1287]